Entellus Medical

2017 News Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
02/21/17Entellus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
PLYMOUTH, Minn., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today reported its financial results for the quarter and year ended December 31, 2016.  Recent Highlights and Accomplishments Revenue of $21.7 million in the fourth quarter of 2016, an increase of 2... 
02/01/17Entellus Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 21, 2017
Conference call scheduled for Tuesday, February 21, 2017 at 3:30pm CT / 4:30pm ET PLYMOUTH, Minn., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced that it will release its financial results for the fourth quarter and full year 2016 after the close of tr... 
01/25/17Entellus Medical Announces Pricing of Public Offering of Common Stock
PLYMOUTH, Minn., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (the “Company” or “Entellus Medical”) (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients, today announced the pricing of its underwritten public offering of 3,530,000 shares of its common stock at a price of $17.00 per share before... 
01/25/17Entellus Medical Announces Proposed Public Offering of Common Stock
PLYMOUTH, Minn., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (the “Company” or “Entellus Medical”) (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients, today announced that it has commenced an underwritten public offering of $60.0 million of shares of its common stock. The offering is expecte... 
01/05/17Entellus Medical Announces Management Promotions and Preliminary Revenue for Fourth Quarter and Full Year 2016
PLYMOUTH, Minn., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced the promotion of Thomas Williamson to the position of Vice President of Sales; the resignation of Jim Surek as Vice President of Sales, and the promotion of Jonelle Burnham to the position of...